A Single-arm, open-label, Phase II study of sabatolimab in combination with azacitidine and venetoclax in adult participants with high or very high risk myelodysplastic syndrome (MDS) as per IPSS-R criteria
- Tiong, Ing Soo (Primary Chief Investigator (PCI))
- Kennedy, Nola (Project Manager)
Project: Research